Loading Events

Go Back

event image

Best Practices in Lung Cancer

June 29, 2021

OVERVIEW

Our panel of experts will be discussing the Targeted Therapy for ALK-mutated NSCLC​ and the Therapeutic Options for R/R ROS1 Mutated NSCLC​.